QD Laser
Yokohama, JP Β· Public Β· 24 known investors
QD Laser develops, manufactures, and sells high-efficiency semiconductor lasers for telecommunications and industrial use, as well as visual-information devices. The company is based in Yokohama, Japan and is listed on the Tokyo Stock Exchange Growth Market.
Also known as QD Laser, Inc. Β· QDγ¬γΌγΆ Β· ζ ͺεΌδΌη€ΎQDγ¬γΌγΆ
Founders & leadership

Investors Β· 24
Also in the syndicate Β· 16
Company profile
researched Aug 2026QD Laser, Inc. is a Yokohama-based optical device company established in April 2006 to commercialise quantum dot laser technology originating at Fujitsu Laboratories, with venture capital from Fujitsu and Mitsui & Co. It is listed on the Tokyo Stock Exchange Growth Market under securities code 6613. The company organises its activities around sensing, precision (non-thermal) micromachining, silicon photonics and its VISIRIUM retinal-projection technology, and holds a second-class marketing licence for medical devices in Japan as well as ISO9001 (2012) and EN ISO 13485 (2019) certifications.
The laser device business supplies semiconductor lasers, gain chips and GaAs-based epitaxial wafers: compact visible lasers at 532/561/594 nm (DFB plus wavelength-conversion element, 5β50 mW, CW/nanosecond/50 ps pulsed) for biomedical instruments such as flow cytometers, microscopes and spectroscopy; high-power Fabry-Perot lasers from 640 to 940 nm in TO-56 packages (up to 250 mW) for machine vision, leveling instruments, particle counters and other sensors; single-mode DFB lasers spanning roughly 1020β1188 nm, selectable in 1 nm steps, used as picosecond/nanosecond seeders for fiber lasers in micromachining, inspection and LiDAR, with matching driver boards; and quantum dot lasers at 1240β1330 nm for optical communication and silicon photonics that operate stably at high temperatures (cited up to 200 Β°C, including downhole resource exploration at 175β200 Β°C). A foundry service offers epitaxy on 3- and 4-inch GaAs substrates (InAs quantum dot, InGaAs quantum well, GaAs, AlGaAs layers) plus grating formation and regrowth. The "Lantana" all-in-one compact visible laser was released in October 2024.
The medical and welfare line applies retinal projection to low vision. Products and milestones include the RETISSA Display (corporate orders from April 2018, individual orders from October 2018), RETISSA Display II (advance orders October 2019, eBay sales from 2021), the RETISSA MEDICAL medical device (Japanese manufacturing and sales approval January 2020, sales from March 2021), the RETISSA NEOVIEWER viewfinder and RETISSA ON HAND magnifier (domestic sales from March 2023, rentals from November 2023), the Retissa Super Capture laser retinal imaging camera, and the smartphone-compatible RETISSA VIEWCLEAR accessory. The company's image-quality evaluation method for scanning retinal projection devices was published as IEC 62906-5-5:2022.
Founding story
QD Laser was established in April 2006 as an optical device venture built on Fujitsu quantum dot laser technology, funded by venture capital from Fujitsu Ltd. and Mitsui & Co., and spun out of Fujitsu Laboratories following collaboration with Mitsuru Sugawara, a professor at the University of Tokyo's Institute of Industrial Science. In the same month it signed a research outsourcing contract with Fujitsu Laboratories on quantum dot lasers and optical amplifiers, and in June 2006 concluded a joint research agreement with the University of Tokyo on quantum dot crystal growth technology.
Business model
QD Laser sells hardware through two product lines: semiconductor laser devices, chips and epitaxial wafers supplied to industrial, sensing, biomedical and optical-communication customers (including customised parts and foundry epitaxy, with support from prototyping through mass production), and retinal-projection consumer/medical devices under the RETISSA brand sold or rented to organisations and individuals. Devices are sampled and quoted on request via direct inquiry, and some products (e.g. RETISSA ON HAND) are also offered on a rental basis.
Revenue comes from sales of laser modules, chips and epitaxial wafers, foundry epitaxy services, and sales and rentals of RETISSA retinal-projection products, including a medical device sold under a Japanese second-class medical device marketing licence.
Traction
Milestones include commercial mass production of quantum dot lasers for 10 Gbps optical communication (2009), a catalogued product portfolio spanning visible, high-power FP, DFB and quantum dot lasers plus epitaxial wafers, Japanese regulatory approval and sales of the RETISSA MEDICAL device, adoption of RETISSA Display in a Fujitsu/Nohgaku Performers' Association ICT initiative (2019), completion of a European clinical trial of RETISSA Medical (June 2021), standardisation of its retinal-projection image-quality evaluation method as IEC 62906-5-5:2022, and a business collaboration with TDK on XR glass optical engines (2026). Media coverage has included Forbes (2019), NHK WORLD BIZ STREAM (2024) and Japanese broadcast programmes.
Latest developments
Recent items on the company's sites include a business collaboration contract with TDK for XR glass optical engines using retinal projection technology (June 2026), the start of test marketing for the smartphone-compatible RETISSA VIEWCLEAR retinal projection accessory (May 2026), headquarters relocation and start of operations at the Yokohama-Totsuka Site in April 2026, a presentation at the Japan-Taiwan Silicon Photonics Technology Symposium (July 2026), exhibitions at SPIE Photonics West 2026 and Laser Solution 2026, the addition of 850 nm 200 mW Fabry-Perot lasers (2024), and the launch of the Lantana compact visible laser (October 2024).
βΈFull profile β market position, technology, go-to-market, geography, history
Market position
QD Laser is a University of Tokyo/Fujitsu-linked photonics company that reported the world's first commercial mass production of quantum dot lasers for 10 Gbps optical communication in March 2009 and has accumulated recognition including a Wall Street Journal Technology Innovation Awards runner-up (2006), IEEE Spectrum "Winner for Telecommunications" (2009), Green IT Awards METI Award (2010), the IEEE Photonics Society Aron Kressel Award (2014), the 1st JEITA Venture Awards (2016), the 16th Yamazaki Teiichi Prize (2016), CEATEC JAPAN 2016 US Media Panel Innovation Awards Grand Prix and METI Award, Photonics West Prism Awards (2017 and 2019) and the WIRED Audi Innovation Award 2017.
Differentiators cited by the company include quantum dot lasers with high-temperature stability and high optical-feedback tolerance for optical communication and silicon photonics; visible laser modules based on a DFB plus wavelength-conversion design that, unlike DPSS lasers, allow high-speed modulation with low power consumption in a compact proprietary package; DFB seed lasers selectable in 1 nm steps with picosecond gain-switch operation for non-thermal micromachining; and VISIRIUM retinal-projection optics applied to both low-vision assistive devices and XR glasses.
Technology
The company's technology base is GaAs-based semiconductor laser fabrication, including InAs quantum dot and InGaAs quantum well epitaxial structures. Quantum dot lasers provide stable operation at high temperature (world-first -40 to 100 Β°C operation for optical communication demonstrated in 2008; up to 200 Β°C cited for current products) and high optical-feedback tolerance. Visible-wavelength modules combine a DFB laser with a PPLN wavelength-conversion element to yield modulatable 532/561/594 nm output, in contrast to non-modulatable DPSS lasers. DFB seed lasers support gain-switched 50 ps and 15 ps pulses for fiber-laser micromachining, enabling non-thermal processing that finishes material before heat-induced change. VISIRIUM technology precisely manipulates laser light to scan images directly onto the retina, and the same optical engine approach is being applied to XR glasses. The company also works on silicon photonics light sources, which it states could cut data-centre power consumption by 30% or more.
Go-to-market
Products are marketed via direct sales and inquiry/quotation forms, dedicated satellite sites for semiconductor lasers and epitaxial wafers (available in Japanese, English and simplified Chinese) and a RETISSA-specific site, supported by trade-show presence at SPIE Photonics West, LASER World of PHOTONICS, OPIE, CEATEC, InterOpto and the CSUN Assistive Technology Conference, and by LinkedIn activity from the Laser Device Division. Retail and rental channels have been used for retinal projection products, including eBay sales of RETISSA Display II from August 2021 and test marketing of RETISSA VIEWCLEAR from May 2026. A business collaboration with TDK covers XR glass optical engines, and an analyst report by Shared Research was published in September 2024.
Industrial and instrument makers needing laser sources for micromachining seeders, inspection, LiDAR, machine vision, leveling instruments and particle counters; biomedical equipment makers (flow cytometers, microscopes, spectroscopy); optical communication and silicon photonics system builders including data centres, high-performance computing, automotive and mobile infrastructure; resource-exploration users needing high-temperature operation; and people with low vision plus clinical and assistive-technology channels for RETISSA products.
Geography
Headquarters are at 206-1 Kamikurata-cho, Totsuka-ku, Yokohama, Kanagawa Prefecture, Japan; the head office was relocated and operations began at the Yokohama-Totsuka Site (YTS) in April 2026. A non-consolidated US subsidiary, QD Laser America, Inc. (capital $10,000), was established in Delaware in August 2022 to sell retinal projection products. Product information is published in Japanese, English and simplified Chinese, and the company exhibits in the United States, Europe and Asia.
History
After its 2006 founding, QD Laser received NEDO grants for practical development of quantum dot lasers (2006) and quantum dot DFB lasers (2008) for optical communication, demonstrated the world's first quantum dot laser for optical communication operating from -40 to 100 Β°C in February 2008, and began the world's first commercial mass production of 10 Gbps quantum dot lasers in March 2009. It raised roughly 700 million yen in December 2008 led by Mizuho Capital and about 800 million yen in December 2010 from existing shareholders. Product expansion followed with 1064 nm DFB modules (2011, 400 mW in 2014), compact green/yellow-green/orange modules (2012), a picosecond pulse driver board (2014) and a wearable "Laser Eyewear" terminal (2014). Retinal projection work advanced through an SLO study group and the MERIT consortium in 2016, RETISSA Display orders from 2018, EN ISO 13485 certification in 2019, RETISSA MEDICAL approval in January 2020 and sales in March 2021. A third-party share allocation was carried out in April 2019. The company listed on the TSE Mothers Market in February 2021 and moved to the Growth Market in April 2022, established QD Laser America in August 2022, launched RETISSA NEOVIEWER and RETISSA ON HAND in March 2023 and the Lantana visible laser in October 2024.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 26
launches, deals, and filingsQD Laser and TDK entered a business collaboration contract to develop optical engines for XR glasses based on QD Laser's retinal projection technology.
Start of test marketing for RETISSA VIEWCLEAR, a smartphone-compatible retinal projection accessory.
The company relocated its headquarters to a new office and launched operations at the Yokohama-Totsuka Site.
QLF083x-50B0 (850 nm, CW 200 mW) added to the high-power FP laser lineup.
All-in-one compact visible laser at 532, 561 and 594 nm made available, with sample orders accepted.
Non-consolidated US subsidiary with capital of $10,000 set up to sell retinal projection products.
$10K source β
Moved market segment following reorganisation of the Tokyo Stock Exchange.
The company's method for evaluating overall image quality of scanning retinal projection devices was published as an IEC standard.
Licence number 14B2X10039, approved 16 March 2017.
Awarded to Mitsuru Sugawara, Keizo Takemasa and Kenichi Nishi.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
βΈResearch sources Β· 8
primary sources listed
- QD Laserqdlaser.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does QD Laser do?
- Japanese semiconductor laser maker (TSE Growth: 6613) selling quantum dot and visible lasers plus RETISSA retinal-projection products.
- Who founded QD Laser?
- QD Laser was founded by Mitsuru Sugawara, θ ε ε .
- Who are QD Laser's investors?
- QD Laser's investors include Beyond Next Ventures, MIRAI SOUZOU, Mitsui Global Investment, Oita Venture Capital, SMBC Venture Capital, UntroD Capital, UTokyo Innovation Platform Co. Ltd., Tokyo Century.
- Where is QD Laser headquartered?
- QD Laser is headquartered in Yokohama, JP.
